Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna Inc    AET

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

HMO investors breathe easier about health law ruling

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/30/2012 | 05:41pm CEST

Now that the Supreme Court has given a glimpse of how it will consider the healthcare overhaul, more investors in health insurance stocks are breathing easier about the eventual ruling.

Wall Street is less worried about the worst-case scenario for insurers: that the court strikes down the individual mandate requiring people buy insurance, but keeps in place provisions that could force insurers to cover more sick, high-cost Americans.

Investors also increasingly believe the whole law may be tossed out, analysts said, which could boost health insurer stocks in the near term. Several analysts pointed to UnitedHealth Group as a stock that should do well regardless of the ruling, while Aetna Inc has been a strong performer this week.

The high court heard three days of arguments over the law championed by President Barack Obama this week, with close scrutiny paid to every question posed by its justices.

Legal and political commentators saw shared support for the law among the court's four liberal appointees, but question whether Obama's administration will win over one of five conservative justices needed to keep the law intact.

As the nation waits for a ruling in late June, the thesis for healthcare investors has changed slightly, analysts and fund managers say.

In the worst-case scenario, the court strikes down the individual mandate, which requires people buy insurance or face a penalty, while maintaining provisions that force insurers to offer coverage regardless of health status.

Insurers have said that the mandate is necessary to ensure that healthy people are in the insurance pool, because without it they would only see an influx of sick, high-cost consumers.

But given the court's debate, analysts said, investors are discounting chances of such a partial decision.

"Investors gained comfort with the operating environment that (health insurers) are going to have," Jefferies & Co analyst David Windley said. "The worst case is now unlikely."

Analysts cautioned that health insurer stocks could tumble 5 percent or perhaps much more if the individual mandate alone is struck down.

"People at this point have pretty much dismissed the potential for an adverse outcome here, which would be the individual mandate gets tossed and everything else remains the same," Susquehanna Financial Group analyst Chris Rigg said.

Shares of large health insurers outperformed the market this week, and posted significant gains on Thursday.

Aetna jumped 6.5 percent on Thursday, while Coventry Health Care rose 5.9 percent and UnitedHealth and Cigna Corp both climbed more than 4 percent.

For the week, the Morgan Stanley Healthcare Payor index of insurers rose about 6 percent through Thursday against roughly flat performance for the broader S&P 500 index.

THESIS CHANGING

Going into the start of the debate on Monday, the consensus among investors was that the law will be upheld -- a decision viewed as modestly positive for insurer stocks because it would create more certainty about their business in the coming years.

But the high court's debate created the impression among many on Wall Street that there is a greater chance the mandate is at risk, and possibly the entire law.

For example, former Aetna Chief Executive Ron Williams told CNBC television on Thursday he now believed that the individual mandate, had a "high probability" of being overturned.

"Going into the debate on the mandate, there was almost a sense of complacency out there that the mandate would stand, as would the law," CRT Capital analyst Sheryl Skolnick said. "Investors were thrown a curve ball."

However, should the mandate be struck down, the most likely scenario is that the court will also strike down provisions that require insurers enroll all individuals regardless of health status, according to Sanford Bernstein analyst Ana Gupte.

This scenario is positive for insurers because it eliminates risks from enrolling potentially unprofitable members through the new insurance exchanges to be created by the law, but would still allow the companies to increase their membership through the expansion of the Medicaid health program for low-income Americans.

Gupte called the court's developments this week "thesis-changing" for investors given that the diminished chance of the worst-case decision and the improved odds for the more positive scenario.

Thursday's rise for insurer stocks indicated that investors also may have been pricing in the court overturning the entire law, according to analysts at Goldman Sachs.

Such a ruling would also create uncertainty for the insurers, but could help their stocks in the near term by eliminating new regulations viewed as onerous to the industry.

OVERTURN NEGATIVE FOR HOSPITALS, MEDICAID COS

Wall Street generally agrees that an overturn would hurt hospital companies. The law stands to increase the potential pool of paying patients by providing coverage for more than 30 million uninsured, many of whom otherwise might seek care but leave hospitals with unpaid bills.

Hospitals shares have traded lower during the week. Through Thursday, HCA Holdings fell 4.6 percent, Tenet Healthcare declined 1.7 percent and Community Health Systems slipped 0.9 percent.

"They could experience some additional weakness," CRT's Skolnick said. "I can't see where first-quarter earnings are going to generate a rally. I think they're going to be range-bound."

At the same time, Skolnick said, "Should reform pass this test completely, you wouldn't want to be short the hospitals."

Shares of insurers that specialize in Medicaid also may come under pressure ahead of the decision. The law is set to significantly expand Medicaid, providing a new growth opportunity for these smaller insurers.

Although the consensus seemed to be that the court would uphold the specific portion dealing with the Medicaid expansion, an overturn of the entire law could negate the expansion.

For now, investors do not seem overly concerned about this possibility: Shares of Medicaid specialists Amerigroup and Molina Healthcare both rose 1.7 percent for the week through Thursday, while Centene climbed 5.7 percent.

Oppenheimer & Co analyst Michael Wiederhorn said to expect some volatility among such companies until June, but said he'd "use weakness in the Medicaid names as a buying opportunity."

"When you look at the big picture of the Medicaid names, states are still struggling," Wiederhorn said. "States will continue to outsource this business."

Even as investors placed bets, some analysts maintained that nothing definite emerged from the three-day proceedings.

"It's a fool's game to try to figure out a 5-4 vote one way or another," Wiederhorn said.

(Reporting By Lewis Krauskopf; Editing by Michele Gershberg and Derek Caney)

By Lewis Krauskopf

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AETNA INC
06/21 AETNA : and Community Care Physician Network Sign Collaborative Agreement
06/20 U.S. banks, corporations establish principles for cyber risk ratings firms
06/19 AETNA : Florida governor tries again to lure Connecticut firms
06/18 INSURERS LEAVING OBAMACARE IN DROVES : Insurers leaving troubled Obamacare in dr..
06/16 AETNA : Casey Still 'Fighting Like Hell' for Obamacare
06/13 AETNA : Sutter Health and Aetna to Establish New Health Plan in Northern Califor..
06/07DJAETNA : Tax Quirk Pushes City Toward Bankruptcy Tax-Exempt Property Weighs On Ha..
06/07DJAnthem to Pull Out of Ohio Affordable Care Act Exchange -- 2nd Update
06/06DJAETNA : Hartford's Finances Spotlight Property-Tax Quandary -- Update
06/06DJAETNA : Hartford's Finances Spotlight Property-Tax Quandary
More news
Sector news : Managed Healthcare - NEC
03:02aDJANTHEM : Pulling Back on Offering ACA Plans in Nevada - Update
06/28DJANTHEM : Pulling Back on Offering ACA Plans in Nevada
06/27DJANTHEM : Senate Health Bill Raises Uninsured by 22 Million in 2026 Compared to A..
06/26DJANTHEM : Says Senate Health Bill Will Bolster Individual Insurance Market -- Upd..
06/23DJANTHEM : Agrees to $115 Million Settlement of Data Breach Lawsuit
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
06/28 GOP leadership aims for Friday deal on healthcare bill
06/28 Premarket analyst action - healthcare
06/27 Stocks fall to day's lows as Senate delays health care vote
06/27 CBO evaluates Senate health bill
06/22 Changes aplenty in GOP's healthcare bill, but not a radical departure from AC..
Advertisement
Financials ($)
Sales 2017 61 036 M
EBIT 2017 4 253 M
Net income 2017 1 841 M
Debt 2017 2 991 M
Yield 2017 0,95%
P/E ratio 2017 28,87
P/E ratio 2018 16,24
Capi. / Sales 2017 0,87x
Capi. / Sales 2018 0,78x
Capitalization 50 150 M
More Financials
Chart AETNA INC
Duration : Period :
Aetna Inc Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Full-screen chart
Technical analysis trends AETNA INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 152 $
Spread / Average Target 0,85%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC21.92%50 150
UNITEDHEALTH GROUP15.67%177 892
ANTHEM INC30.35%49 661
CIGNA CORPORATION25.23%42 767
HUMANA INC15.06%34 213
CENTENE CORP43.36%13 956
More Results